Cargando…

BioSense

BioSense is part of the US CDC's Public Health Information Network (PHIN) framework managed through the CDC BioIntelligence Center. It supports early outbreak detection at the local, state, and national levels, by monitoring the size, location, and rate of spread of an outbreak; monitoring seas...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hsinchun, Zeng, Daniel, Yan, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498871/
http://dx.doi.org/10.1007/978-1-4419-1278-7_7
_version_ 1783583604999192576
author Chen, Hsinchun
Zeng, Daniel
Yan, Ping
author_facet Chen, Hsinchun
Zeng, Daniel
Yan, Ping
author_sort Chen, Hsinchun
collection PubMed
description BioSense is part of the US CDC's Public Health Information Network (PHIN) framework managed through the CDC BioIntelligence Center. It supports early outbreak detection at the local, state, and national levels, by monitoring the size, location, and rate of spread of an outbreak; monitoring seasonal trends of influenza and other disease indicators; and assisting in case-finding for epidemiologic investigations. In March 2005, BioSense had more than 340 state and local health department user accounts, representing 49 states. Its user base continues to expand. The current implementation status of BioSense (as of June 2008) is shown in Figure 7-1. The system has also been used in several high-profile events (e.g., the G8 meeting in 2004) (Bradley et al., 2005; Ma et al., 2005; Sokolow et al., 2005).
format Online
Article
Text
id pubmed-7498871
institution National Center for Biotechnology Information
language English
publishDate 2009
record_format MEDLINE/PubMed
spelling pubmed-74988712020-09-18 BioSense Chen, Hsinchun Zeng, Daniel Yan, Ping Infectious Disease Informatics Article BioSense is part of the US CDC's Public Health Information Network (PHIN) framework managed through the CDC BioIntelligence Center. It supports early outbreak detection at the local, state, and national levels, by monitoring the size, location, and rate of spread of an outbreak; monitoring seasonal trends of influenza and other disease indicators; and assisting in case-finding for epidemiologic investigations. In March 2005, BioSense had more than 340 state and local health department user accounts, representing 49 states. Its user base continues to expand. The current implementation status of BioSense (as of June 2008) is shown in Figure 7-1. The system has also been used in several high-profile events (e.g., the G8 meeting in 2004) (Bradley et al., 2005; Ma et al., 2005; Sokolow et al., 2005). 2009-07-14 /pmc/articles/PMC7498871/ http://dx.doi.org/10.1007/978-1-4419-1278-7_7 Text en © Springer Science+Business Media, LLC 2010 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Chen, Hsinchun
Zeng, Daniel
Yan, Ping
BioSense
title BioSense
title_full BioSense
title_fullStr BioSense
title_full_unstemmed BioSense
title_short BioSense
title_sort biosense
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498871/
http://dx.doi.org/10.1007/978-1-4419-1278-7_7
work_keys_str_mv AT chenhsinchun biosense
AT zengdaniel biosense
AT yanping biosense